<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01598909</url>
  </required_header>
  <id_info>
    <org_study_id>ARINE Study</org_study_id>
    <nct_id>NCT01598909</nct_id>
  </id_info>
  <brief_title>Efficacy of Arnica D1 Ointment After Upper Blepharoplasty</brief_title>
  <acronym>ARINE</acronym>
  <official_title>Efficacy of Arnica D1 Ointment After Upper Blepharoplasty: a Randomized, Double-blind Placebo-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wynand BWH Melenhorst, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isala</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arnica ointment is currently used in homeopathic preparations for strains and bruises. In the
      field of plastic surgery, some surgeons advise patients undergoing blepharoplasty to use
      Arnica in order to prevent postoperative ecchymosis, swelling and pain. Thus far, no decent
      study evaluated the efficacy of topical Arnica ointment in reducing ecchymosis or surgical
      outcome after upper blepharoplasty. We hypothesize that application of Arnica ointment
      postoperatively will reduce the development of ecchymosis and improve outcome.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical outcome</measure>
    <time_frame>7 days and 6 weeks postoperatively</time_frame>
    <description>Overall judgment of surgical outcome, based on the combined analysis of the amount of ecchymosis, swelling and redness, by an unrelated, uninvolved and &quot;blinded&quot; plastic surgeon.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>amount of tissue swelling; redness; pain; postoperative recovery; patient satisfaction</measure>
    <time_frame>3, 7 and 42 days postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">136</enrollment>
  <condition>Blepharoplasty</condition>
  <condition>Upper Eyelid Blepharoplasty</condition>
  <arm_group>
    <arm_group_label>Arnica ointment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo ointment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arnica</intervention_name>
    <description>Application of Arnica ointment periorbitally</description>
    <arm_group_label>Arnica ointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo ointment</intervention_name>
    <description>Application of Arnica ointment, twice a day, for the period of one week.</description>
    <arm_group_label>Placebo ointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing primary blepharoplasty

        Exclusion Criteria:

          -  use of anticoagulants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>W Melenhorst, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Isala Klinieken, Zwolle</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Isala Klinieken</name>
      <address>
        <city>Zwolle</city>
        <zip>8000 GK</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2012</study_first_submitted>
  <study_first_submitted_qc>May 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2012</study_first_posted>
  <last_update_submitted>August 21, 2015</last_update_submitted>
  <last_update_submitted_qc>August 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Isala</investigator_affiliation>
    <investigator_full_name>Wynand BWH Melenhorst, MD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>blepharoplasty</keyword>
  <keyword>arnica</keyword>
  <keyword>homeopathy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

